Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual reality goggles ease needle pain for kids with cancer

NCT ID NCT04931745

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether virtual reality (VR) can reduce pain and distress in children with cancer when they get a needle put into their port-a-cath. 84 children aged 5 to 17 were randomly assigned to use VR, an iPad, or no special distraction during the procedure. Researchers measured their distress and pain using standard scales.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality headset (Oculus 2)
What this could lead to
If it works, this could give doctors a simple, drug-free way to ease pain and fear for children during needle procedures.
What could go wrong
This is a small, completed trial (84 children). The effect may be modest or not better than simpler distractions like an iPad. Results may not apply to all children or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

84 people

The number who actually took part.

Started

Apr 2022

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children age 5 to 17 years of age who are undergoing port-a-cath access * Pre-intervention Children's Fear Scale score of at least 1 with respect to the impending port-a-cath access Exclusion Criteria: * Subjective report of motion sickness within past 12 months (excluding anticipatory nausea a child may experience en route to their medical appointment) * Subjective history of claustrophobia Requires timely antimicrobial therapy * Visual, auditory, or cognitive impairment or language barrier precluding comprehension of study-related tasks or safe interaction with VR * Medical record documentation of current MRSA infection * Subjective history of concurrent respiratory infection (defined as cough, sore throat, fever, coryza, or sneezing within the past 24 hours) or gastrointestinal infection (defined as any vomiting or diarrhea within past 24 hours) * Previous enrollment in study * Seizure disorder * History of vertigo or neurological disorder that creates moderate to severe dizziness.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Cancer Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • London Health Sciences Centre

    London, Ontario, N6A5W3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.